Sanofi India share price gained up to 6% in morning trades on Friday post Q4 results announced by the company after the ...

Gain insights into Recursion Pharmaceuticals' Q4 2024 earnings call. Discover clinical advancements, key partnerships, and strategic plans for 2025.

With a market valuation of Rs 11,574.76 Cr, Sanofi Indias shares ended Fridays trading session on the BSE 0.58% higher at Rs ...

Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...

DIsney says it has sold out all commercial inventory for Sunday's Oscars, and notes packages include TV, streaming, social ...

Kymera Therapeutics Inc (KYMR) reports robust financial health and strategic advancements, setting the stage for significant ...

Novavax Inc (NVAX) outlines its strategic focus on partnerships and pipeline expansion while navigating revenue fluctuations ...

Sanofi’s cardiovascular (CV) and central nervous system (CNS) therapies have gained traction, supported by partnerships.

IST, the barometer index, the S&P BSE Sensex, declined 751.63 points or 1% to 73,865. The Nifty 50 index dropped 224.55 points or 1% to 22,320.50.

Operator Good afternoon, and welcome to AbCellera's full-year 2024 business update conference call. My name is Tamia, and I will facilitate the audio portion of today's interactive broadcast.

The company posted earnings per share (EPS) of $1.16,... ByInvesting.com• 4 hours ago Earnings call transcript: Sanofi Q4 2024 sees strong growth in sales, EPS Sanofi (EPA:SASY) (NASDAQ:SNY) reported ...